Skip to main content

Table 4 Postoperative clinicopathological data of all patients enrolled

From: The impact of COVID-19 on gastric cancer surgery: a single-center retrospective study

Clinicopathologic data

PCG(N = 68)

M (IQR) orN (%)

CG (N = 41)

M (IQR) orN (%)

P

Pathological TNM staging

  

0.394

 I

18

8

 

 II

18

10

 

 III

29

23

 

 IV

3

0

 

Complications

  

0.081

 Yes

6

0

 

 No

62

41

 

Postoperative fever

  

0.379

 Yes

29

14

 

 No

39

27

 

Highest temperature (°C)

  

0.587

 < 37.3

39

27

 

 37.3–38.5

22

12

 

 > 38.5

7

2

 

Screening examination

  

0.012*

 None

16

2

 

 BRE + CRP

8

4

 

 BRE + CRP + CT

4

5

 

 Nucleic acid test

0

2

 

Reason of fever

  

0.423

 Abdominal infection

1

0

 

 Pulmonary infection

1

0

 

 Incision infection

4

0

 

 Anastomotic leakage

1

0

 

 Unclear

17

11

 

 None

5

3

 

Transfusion of blood

  

0.422

 Yes

3

4

 

 No

65

37

 

Postoperative hospital stay (day)

7 (6–8)

9 (7–11)

0.000*

Total hospital stay (day)

11 (9–13)

15 (13–19)

0.000*

  1. PCG Pre-COVID-19 group, CG COVID-19 group, BRE Blood routine examination, CRP C-reactive protein, CT Computed tomography, Postoperative fever (≥37.3 °C)
  2. M Median, IQR Inter-quartile range, N Number
  3. * P < 0.05, statistically different